---
validationTarget: '_bmad-output/planning-artifacts/prd.md'
validationDate: '2026-03-08'
inputDocuments:
  - _bmad-output/planning-artifacts/prd.md
  - _bmad-output/planning-artifacts/architecture.md
  - _bmad-output/planning-artifacts/epics.md
  - _bmad-output/planning-artifacts/implementation-readiness-report-2026-03-08.md
validationStepsCompleted:
  - step-v-01-discovery
  - step-v-02-format-detection
  - step-v-03-density-validation
  - step-v-04-brief-coverage-validation
  - step-v-05-measurability-validation
  - step-v-06-traceability-validation
  - step-v-07-implementation-leakage-validation
  - step-v-08-domain-compliance-validation
  - step-v-09-project-type-validation
  - step-v-10-smart-validation
  - step-v-11-holistic-quality-validation
  - step-v-12-completeness-validation
validationStatus: COMPLETE
holisticQualityRating: '4/5 - Good'
overallStatus: 'Warning'
---
# PRD Validation Report

**PRD Being Validated:** `_bmad-output/planning-artifacts/prd.md`
**Validation Date:** 2026-03-08

## Input Documents

- `_bmad-output/planning-artifacts/prd.md`
- `_bmad-output/planning-artifacts/architecture.md`
- `_bmad-output/planning-artifacts/epics.md`
- `_bmad-output/planning-artifacts/implementation-readiness-report-2026-03-08.md`

## Validation Findings

## Format Detection

**PRD Structure:**
- Executive Summary
- User Journeys
- Domain Requirements
- Project-Type Requirements
- Scoping
- Functional Requirements
- Non-Functional Requirements

**BMAD Core Sections Present:**
- Executive Summary: Present
- Success Criteria: Present via `### Business Success` and `### Technical Success`
- Product Scope: Present via `## Scoping`
- User Journeys: Present
- Functional Requirements: Present
- Non-Functional Requirements: Present

**Format Classification:** BMAD Standard
**Core Sections Present:** 6/6

## Information Density Validation

**Anti-Pattern Violations:**

**Conversational Filler:** 0 occurrences

**Wordy Phrases:** 0 occurrences

**Redundant Phrases:** 0 occurrences

**Total Violations:** 0

**Severity Assessment:** Pass

**Recommendation:**
"PRD demonstrates good information density with minimal violations."

## Product Brief Coverage

**Status:** N/A - No Product Brief was provided as input

## Measurability Validation

### Functional Requirements

**Total FRs Analyzed:** 10

**Format Violations:** 0

**Subjective Adjectives Found:** 1
- Line 160: `Low-Friction` and `one obvious next action per screen` remain partly qualitative without an explicit ergonomic metric in the FR wording.

**Vague Quantifiers Found:** 0

**Implementation Leakage:** 0

**FR Violations Total:** 1

### Non-Functional Requirements

**Total NFRs Analyzed:** 6

**Missing Metrics:** 1
- Line 198: `Security` remains testable in intent but does not define a direct quantitative target or measurement method.

**Incomplete Template:** 2
- Line 198: missing explicit measurable threshold and measurement method.
- Line 202: `without perceptible degradation` is still partly qualitative even though concurrency and data-volume thresholds are now stated.

**Missing Context:** 0

**NFR Violations Total:** 3

### Overall Assessment

**Total Requirements:** 16
**Total Violations:** 4

**Severity:** Pass

**Recommendation:**
"Requirements are now largely measurable. Remaining improvements are minor and concentrated in security/scalability wording and FR6 ergonomics phrasing."

## Traceability Validation

### Chain Validation

**Executive Summary → Success Criteria:** Intact
- The executive summary emphasizes reduced administrative friction, controlled reimbursement support, accessibility, and traceability; these themes are reflected in the business and technical success criteria.

**Success Criteria → User Journeys:** Intact
- Physiotherapist, patient, foundation member, and administrator journeys collectively support the declared business and technical outcomes.

**User Journeys → Functional Requirements:** Intact
- Each journey maps to explicit FR coverage, and FR8-FR10 are formally represented in the PRD.

**Scope → FR Alignment:** Intact
- MVP scope and out-of-scope boundaries align with the FR set without obvious scope drift.

### Orphan Elements

**Orphan Functional Requirements:** 0

**Unsupported Success Criteria:** 0

**User Journeys Without FRs:** 0

### Traceability Matrix

| Element | Status | Notes |
|---------|--------|-------|
| Executive Summary → Success | Covered | Vision and success dimensions align |
| Success → Journeys | Covered | Each actor journey supports stated outcomes |
| Journeys → FRs | Covered | FR table and journey references are explicit |
| Scope → FRs | Covered | MVP and out-of-scope framing align with FR set |

**Total Traceability Issues:** 0

**Severity:** Pass

**Recommendation:**
"Traceability chain is intact - all requirements trace to user needs or business objectives."

## Implementation Leakage Validation

### Leakage by Category

**Frontend Frameworks:** 0 violations

**Backend Frameworks:** 0 violations

**Databases:** 0 violations

**Cloud Platforms:** 0 violations

**Infrastructure:** 0 violations

**Libraries:** 0 violations

**Other Implementation Details:** 0 violations

### Summary

**Total Implementation Leakage Violations:** 0

**Severity:** Pass

**Recommendation:**
"No significant implementation leakage found. Requirements properly specify WHAT without HOW."

## Domain Compliance Validation

**Domain:** healthcare
**Complexity:** High (regulated)

### Required Special Sections

**Clinical Requirements:** Present
- The PRD now explicitly frames the product as a non-clinical administrative support platform.

**Regulatory Pathway:** Partial
- Domain requirements mention medical standards, liability considerations, and regulatory pathways for healthcare support, but the applicable path is not yet concretely stated.

**Validation Methodology:** Missing
- There is still no explicit section describing how healthcare-specific compliance assumptions would be validated.

**Safety Measures:** Present
- Privacy, access control, minimization of sensitive data, explicit workflow states, and human validation are now stated as safety assumptions.

### Compliance Matrix

| Requirement | Status | Notes |
|-------------|--------|-------|
| Privacy and data protection | Met | GDPR and Belgian privacy requirements are explicit |
| Sensitive data minimization | Met | PRD explicitly avoids structured sensitive medical data |
| Regulatory pathway clarity | Partial | Mentioned, but not concretely defined |
| Clinical boundary framing | Met | Non-clinical support boundary is explicit |
| Validation methodology | Missing | No healthcare-specific validation approach documented |
| Safety measures | Met | Safety assumptions are now explicitly documented |

### Summary

**Required Sections Present:** 3/4 as explicit or near-explicit sections
**Compliance Gaps:** 2

**Severity:** Warning

**Recommendation:**
"Domain framing is much stronger. A lightweight clarification of regulatory pathway intent and validation approach would likely close the remaining healthcare-adjacent warning."

## Project-Type Compliance Validation

**Project Type:** web_app

### Required Sections

**Browser Matrix:** Present

**Responsive Design:** Present

**Performance Targets:** Present

**SEO Strategy:** Present

**Accessibility Level:** Present

### Excluded Sections (Should Not Be Present)

**native_features:** Absent ✓

**cli_commands:** Absent ✓

### Compliance Summary

**Required Sections:** 5/5 present
**Excluded Sections Present:** 0
**Compliance Score:** 100%

**Severity:** Pass

**Recommendation:**
"All required sections for web_app are present. No excluded sections found."

## SMART Requirements Validation

**Total Functional Requirements:** 10

### Scoring Summary

**All scores ≥ 3:** 100% (10/10)
**All scores ≥ 4:** 100% (10/10)
**Overall Average Score:** 4.7/5.0

### Scoring Table

| FR # | Specific | Measurable | Attainable | Relevant | Traceable | Average | Flag |
|------|----------|------------|------------|----------|-----------|---------|------|
| FR-001 | 5 | 4 | 5 | 5 | 5 | 4.8 |  |
| FR-002 | 5 | 4 | 5 | 5 | 5 | 4.8 |  |
| FR-003 | 5 | 4 | 5 | 5 | 5 | 4.8 |  |
| FR-004 | 5 | 4 | 5 | 5 | 5 | 4.8 |  |
| FR-005 | 5 | 5 | 5 | 5 | 5 | 5.0 |  |
| FR-006 | 4 | 4 | 5 | 5 | 5 | 4.6 |  |
| FR-007 | 5 | 4 | 5 | 5 | 5 | 4.8 |  |
| FR-008 | 5 | 4 | 5 | 5 | 5 | 4.8 |  |
| FR-009 | 5 | 4 | 5 | 5 | 5 | 4.8 |  |
| FR-010 | 5 | 5 | 5 | 5 | 5 | 5.0 |  |

**Legend:** 1=Poor, 3=Acceptable, 5=Excellent
**Flag:** X = Score < 3 in one or more categories

### Improvement Suggestions

**Low-Scoring FRs:**
- None below threshold. FR6 could still be tightened with explicit ergonomic targets if you want stricter BMAD wording.

### Overall Assessment

**Severity:** Pass

**Recommendation:**
"Functional Requirements demonstrate strong SMART quality overall."

## Holistic Quality Assessment

### Document Flow & Coherence

**Assessment:** Good

**Strengths:**
- The document tells a coherent product story from vision through journeys, scope, and requirements.
- Traceability is explicit and substantially improved by the FR table and PRD-to-Epics matrix.
- Minimal UX guardrails are embedded in the right place for implementation readiness without creating a separate UX artifact.
- Scope boundaries are now clearer thanks to the explicit out-of-scope section.

**Areas for Improvement:**
- Success criteria are still partly directional rather than fully measurable.
- Security and one part of scalability wording remain less testable than the rest of the NFR set.
- Healthcare-adjacent validation methodology is still implicit.

### Dual Audience Effectiveness

**For Humans:**
- Executive-friendly: Good
- Developer clarity: Good
- Designer clarity: Good
- Stakeholder decision-making: Good

**For LLMs:**
- Machine-readable structure: Good
- UX readiness: Good
- Architecture readiness: Good
- Epic/Story readiness: Good

**Dual Audience Score:** 4/5

### BMAD PRD Principles Compliance

| Principle | Status | Notes |
|-----------|--------|-------|
| Information Density | Met | Very little filler remains |
| Measurability | Partial | FRs and most NFRs are strong; a few items still need stricter metrics |
| Traceability | Met | Chain is explicit and coherent |
| Domain Awareness | Partial | Healthcare/privacy context is strong, but regulatory-validation framing could still be sharpened |
| Zero Anti-Patterns | Met | No meaningful filler or leakage remains |
| Dual Audience | Met | Works for both human review and downstream AI use |
| Markdown Format | Met | Structure is clean and machine-readable |

**Principles Met:** 5/7

### Overall Quality Rating

**Rating:** 4/5 - Good

### Top 3 Improvements

1. **Quantify the remaining qualitative security and scalability wording**
   Replace the last subjective phrasing with directly testable targets or verification methods.

2. **Clarify healthcare-adjacent validation methodology**
   Add a short statement about how non-clinical scope and compliance assumptions will be checked during implementation and QA.

3. **Tighten success criteria**
   Convert the remaining directional business and technical success bullets into measurable outcomes where practical.

### Summary

**This PRD is:** a strong BMAD PRD, implementation-oriented and traceable, with only minor refinement areas remaining.

**To make it great:** Focus on the top 3 improvements above.

## Completeness Validation

### Template Completeness

**Template Variables Found:** 0
No template variables remaining ✓

### Content Completeness by Section

**Executive Summary:** Complete

**Success Criteria:** Incomplete
- Success criteria are present as `### Business Success` and `### Technical Success`, but several items remain directional rather than fully measurable.

**Product Scope:** Complete

**User Journeys:** Complete

**Functional Requirements:** Complete

**Non-Functional Requirements:** Incomplete
- All NFRs are present, but security wording and one part of scalability wording remain only partially measurable.

### Section-Specific Completeness

**Success Criteria Measurability:** Some measurable

**User Journeys Coverage:** Yes - covers all user types

**FRs Cover MVP Scope:** Yes

**NFRs Have Specific Criteria:** Some

### Frontmatter Completeness

**stepsCompleted:** Present
**classification:** Present
**inputDocuments:** Present
**date:** Missing

**Frontmatter Completeness:** 3/4

### Completeness Summary

**Overall Completeness:** 92%

**Critical Gaps:** 0
**Minor Gaps:** 3
- Success criteria not fully measurable
- Security and scalability wording still partially qualitative
- PRD frontmatter has no dedicated date field

**Severity:** Warning

**Recommendation:**
"PRD has minor completeness gaps. It is usable, but the small remaining gaps should be closed if you want a cleaner BMAD validation outcome."
